Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

EU nod for Novo Nordisk’s Tresiba and Ryzodeg

Reduced risk of hypoglycaemia may give insulin products edge ahead of Sanofi’s Lantus

- PMLiVE

NICE consults on what makes good social care

Citizens Council gives views as UK agency prepares to expand its remit

- PMLiVE

IQWiG knocks back Almirall’s Eklira

Decides added benefit of COPD drug is not proven

- PMLiVE

Eric Green named NIH’s data science lead

Takes role on interim basis as part of expanding plans for data

- PMLiVE

Positive prospects for pharma in Latin America

Latin America offers a healthy proposition for investors when compared to mature, stalling markets with poor growth predictions

- PMLiVE

Publicis Healthcare Group appoints new chief financial officer

Nathalie Le Bos was previously the group’s Europe CFO

- PMLiVE

Novartis’ eye drug Jetrea recommended for EU approval

Set to become first drug treatment for sight-threatening condition vitreomacular traction and macular hole

- PMLiVE

How to future-proof your brand

Step up your branding expertise to ward off untimely competition and negate the passing of the years

- PMLiVE

Pfizer gets CHMP backing for leukaemia drug bosutinib

Provides option for patients resistant to tyrosine kinase inhibitors

- PMLiVE

Allergan gets US approval for Botox in overactive bladder

Could add $200m to annual sales

- PMLiVE

Havas simplifies media operations

New structure part of its continued drive to put digital and content expertise at core

- PMLiVE

Santhera’s Raxone turned down for rare eye condition

EMA concerned about drug's ability to improve eyesight

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links